Remove 2019 Remove Cell Based Assays Remove Pharmacokinetics
article thumbnail

Separating the Hype from the Hyperbole Surrounding FDORA’s Alternatives to Animal Testing under the FD&C Act

FDA Law Blog: Drug Discovery

The definition goes on to list potential options for such tests: cell-based assays, organ chips and microphysiological systems, computer modeling, other nonhuman or human biology-based test methods such as bioprinting, as well as animal tests. FDORA § 3209(a)(2). 42 U.S.C. § 262(k)(2)(A)(i)(I).

article thumbnail

Improving quality control for CAR T cell therapies

Drug Discovery World

Given the risks, it is important to detecta nd screen out RCVs in CAR T cell therapy batches. Cell-based assays often require considerable time to produce results. qPCR delivers results quickly, but manufacturers cannot necessarily use it to guarantee a CAR T cell batch’s safety due to its limited sensitivity.

Therapies 246
article thumbnail

Leadeth me unto Truth and delivereth me from those who have already found it

Molecular Design

With apologies to Manfred Eigen (1927 - 2019) I've just returned to Cheshire from the Caribbean and, to kick off blogging from 2024 I'll share a photo of the orchids at Berwick-on-Sea on the north coast of Trinidad. A theory has only the alternative of being true or false. A model has a third possibility: it may be true, but irrelevant.